VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)
ConditionYellow Fever Vaccine
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorInstitut Pasteur
About this trial
The aim of this study is to compare the immunogenicity induced by yellow fever vaccination administered during pregnancy with that induced by vaccination outside pregnancy, and to assess the maternal and fetal tolerance of this vaccination.
Eligibility criteria
Qualifiers
Person over 18 years of age at the time of the first yellow fever vaccination
Female gender
Oral consent obtained after subject has been informed
Subject covered by Social Security with the exception of Aide Médicale d'Etat
Disqualifiers
Subject having received a second yellow fever vaccination
Persons unable to give informed consent for participation
Women born in areas where yellow fever is endemic
Female adults under legal protection (guardianship or trusteeship)
Trial design
Treatments tested in this trial
- Blood sample collection
Treatment groups
270 Participants
are divided into 2 treatment groupsSponsors and collaborators
Institut Pasteur
Lead sponsor
Cerballiance
Collaborator
Source ClinicalTrials.gov